Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP2A | P11388 | 2/20 | 0.40 |
| ▸ | NQO2 | P16083 | 6/20 | 0.37 |
| ▸ | NQO1 | P15559 | 5/20 | 0.37 |
| ▸ | MITF | O75030 | 1/20 | 0.37 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.36 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | EHMT2 | Q96KQ7 | 4/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 3/20 | 0.36 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.35 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8796279 | 0.92 | TOP2A (0.46) | TOP2ANQO2NQO1MITFSMARCA2 | |
| SCHEMBL7809103 | 0.91 | TOP2A (0.46) | TOP2ANQO2NQO1MITFSMARCA2 | |
| SCHEMBL7809335 | 0.89 | TOP2A (0.44) | TOP2ANQO2NQO1MITFSMARCA2 | |
| SCHEMBL7818947 | 0.85 | TOP2A (0.44) | TOP2ANQO2NQO1MITFSMARCA2 | |
| SCHEMBL7805085 | 0.84 | ECE1 (0.40) | TOP2AEHMT2KAT2BTOP2BMALT1 | |
| SCHEMBL7804639 | 0.84 | ECE1 (0.40) | TOP2ANQO2NQO1SMN1; SMN2EHMT2 | |
| SCHEMBL7810019 | 0.84 | TOP2A (0.45) | TOP2ANQO2NQO1BRCA1SMN1; SMN2 | |
| SCHEMBL8795843 | 0.83 | TOP2A (0.52) | TOP2ANQO2NQO1MITFSMARCA2 | |
| SCHEMBL7809049 | 0.82 | EHMT2 (0.39) | TOP2ANQO2NQO1MITFEHMT2 | |
| SCHEMBL9388108 | 0.81 | NQO1 (0.44) | TOP2ANQO1BRCA1SMN1; SMN2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0750619-B1 | HETERO-ANNULATED INDAZOLES | NOVUSPHARMA SPA (IT) | 2001-05-30 | — | — | EP | claimed |
| EP-0750619-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) | 1997-01-02 | — | — | EP | claimed |
| WO-1995024407-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) | 1995-09-14 | — | — | WO | claimed |
| EP-0750619-B1 | HETERO-ANNULATED INDAZOLES | NOVUSPHARMA SPA (IT) | 2001-05-30 | — | — | EP | disclosed |
| US-5596097-A | ANTITUMOR AGENTS | THE UNIVERSITY OF VERMONT (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0750619-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) | 1997-01-02 | — | — | EP | disclosed |
| WO-1995024407-A1 | HETERO-ANNULATED INDAZOLES | BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) | 1995-09-14 | — | — | WO | disclosed |